# Pacific Biosciences of California, Inc.: Form 8-K, filed Aug 5, 2026

- Company: [Pacific Biosciences of California, Inc.](/companies/pacb.md) (CIK 1299130)
- Form: 8-K
- Filed: 2026-08-05
- Accepted by EDGAR: Aug 5, 2026, 16:23 ET
- Period: 2026-07-30
- Accession: 0001299130-26-000117
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1299130/000129913026000117/pacb-20260730.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1299130/000129913026000117/

## Items reported

- Item 2.02: Results of operations
- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1299130/000129913026000117/pacb-20260730.htm

Filed Aug 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001299130-26-000117. Last ingested by Listed: Nov 6, 2026, 13:10 ET. No prices; not investment advice.